Browsing category:

Press Release


LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through Commercialization Boca Raton, Florida, July 27, 2020 – LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The[…]

Read More

High Quality APIs For503B Outsourcing Facilities

Erlanger, Kentucky, June 24, 2019 – LGM Pharma, LLC, a leader in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management to the pharmaceutical and biotechnology industries, today reported that it is offering an expanded set of value-added services to support its clients who supply APIs to compounding pharmacies under section 503B of the[…]

Read More

LGMPharma-Orphanion

March 18, 2019, Basel, Switzerland and Erlanger, Kentucky, USA – Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, LLC, a leader in API sourcing, warehousing and distribution services to the pharmaceutical and biotechnology industries, today announced that they have finalized a partnering[…]

Read More

Hamilton Lenox Joins LGM Pharma as Senior VP of Business Development

ERLANGER, Kentucky / BOCA RATON, Florida — LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Hamilton J. Lenox as Senior Vice President of Business Development at the Boca Raton, Florida location. In this capacity, Mr. Lenox will[…]

Read More

LGM Pharma Announces New CEO

ERLANGER, Kentucky / Boca Raton, Florida—LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New York and Israel recently announced that Dr. Prasad S. Raje, Ph.D. would be joining the organization as the company CEO. In that capacity, Dr. Raje will be heading up all company management[…]

Read More

New Harbor Capital

Chicago-based private equity firm New Harbor Capital completed a majority equity investment in LGM Pharma, an innovation-driven company involved in distribution of cGMP active pharmaceutical ingredients (“API”) and other value-added services supporting leading pharmaceutical companies. LGM specializes in streamlining the API supply chain throughout all development stages while providing complete technical capabilities and expert regulatory[…]

Read More

NASHVILLE, Tennessee – LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, announced the launch of their newly redesigned website at www.lgmpharma.com. This is part of their rebranding initiative and reflects their evolving business strategy to support their clients throughout the entire pathway of[…]

Read More

NASHVILLE, Tennessee — Representatives from LGM Pharma, a leading supplier of active pharmaceutical ingredients to various global pharmaceutical firms, headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, recently attended the CPhI Worldwide 2015 conference in Madrid, Spain. CPhI is the world’s leading pharmaceutical platform that brings together pharma ingredients manufacturers, suppliers and[…]

Read More

DCAT Week is one of the largest gatherings in the world for the pharmaceutical and related industries. NASHVILLE, Tennessee – Representatives from LGM Pharma, a leading supplier of active pharmaceutical ingredients to various global pharmaceutical firms, Headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, will participate in the Drug, Chemical & Associated[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service